-
Nu.Q® Technology
Our technology detects characteristic epigenetic changes in nucleosomes that occur from the earliest stages of cancer, sepsis and other diseases.
-
- Our Tests
- Human Health
-
Nu.Q® NETs
Nu.Q® NETs is a groundbreaking CE-marked diagnostic solution that clinicians can use to detect NETosis.
-
Nu.Q® Discover
Buy our Nu.Q® Discover H3.1 Research Use Only Assay
- Animal Health
-
Nu.Q® Vet Cancer Test
Nu.Q® Vet Cancer Test detects 76% of systemic cancers at 97% specificity.
Following last year’s Scientific Advisory Board meeting, our Scientific Advisory Board met again to guide the various projects we are working on, while ensuring we are asking clinically relevant questions while we continue our research.
Hear from Volition Chief Innovation Officer, Terry Kelly, in her video below.
Subscribe for Volition product updates.
Or, click here for Investor Updates and press releases.
"*" indicates required fields